Jianfei Qi1, Lingling Fan, Arif Hussain. 1. aDepartment of Biochemistry and Molecular Biology bGreenebaum Cancer Center, University of Maryland School of Medicine cBaltimore VA Medical Center, Baltimore, Maryland, USA.
Abstract
PURPOSE OF REVIEW: Significant advances have been made in the study of ubiquitination-mediated regulation of androgen receptor (AR). This review will highlight the latest developments in the mechanisms by which E3 ubiquitin ligases control AR activity, with implications in castration-resistant prostate cancer (CRPC). RECENT FINDINGS: Several ubiquitin ligases have been identified to interact with and ubiquitinate AR, and consequently regulate the AR transcriptional programme. Different ubiquitin ligases can use distinct mechanisms to modulate the expression of AR target genes, including local turnover of AR chromatin complex, recruitment of AR coactivators and global AR stability. The expression or activity of ubiquitin ligases can be altered in prostate cancer and thus contribute to the growth of androgen-insensitive prostate cancer cells by modulating the AR transcriptional activity. SUMMARY: Understanding the regulation of AR transcriptional activity by ubiquitin ligases will contribute to the elucidation of mechanisms underlying AR reactivation that is believed to drive the development of CRPC. Ubiquitin ligases could potentially serve as promising targets for developing therapeutics in the treatment of advanced prostate cancers.
PURPOSE OF REVIEW: Significant advances have been made in the study of ubiquitination-mediated regulation of androgen receptor (AR). This review will highlight the latest developments in the mechanisms by which E3 ubiquitin ligases control AR activity, with implications in castration-resistant prostate cancer (CRPC). RECENT FINDINGS: Several ubiquitin ligases have been identified to interact with and ubiquitinate AR, and consequently regulate the AR transcriptional programme. Different ubiquitin ligases can use distinct mechanisms to modulate the expression of AR target genes, including local turnover of AR chromatin complex, recruitment of AR coactivators and global AR stability. The expression or activity of ubiquitin ligases can be altered in prostate cancer and thus contribute to the growth of androgen-insensitive prostate cancer cells by modulating the AR transcriptional activity. SUMMARY: Understanding the regulation of AR transcriptional activity by ubiquitin ligases will contribute to the elucidation of mechanisms underlying AR reactivation that is believed to drive the development of CRPC. Ubiquitin ligases could potentially serve as promising targets for developing therapeutics in the treatment of advanced prostate cancers.
Authors: Marco A Calzado; Laureano de la Vega; Andreas Möller; David D L Bowtell; M Lienhard Schmitz Journal: Nat Cell Biol Date: 2008-11-30 Impact factor: 28.824
Authors: Jean-Philippe P Theurillat; Namrata D Udeshi; Wesley J Errington; Tanya Svinkina; Sylvan C Baca; Marius Pop; Peter J Wild; Mirjam Blattner; Anna C Groner; Mark A Rubin; Holger Moch; Gilbert G Prive; Steven A Carr; Levi A Garraway Journal: Science Date: 2014-10-02 Impact factor: 47.728
Authors: André Catic; Carol Y Suh; Cedric T Hill; Laurence Daheron; Theresa Henkel; Keith W Orford; David M Dombkowski; Tao Liu; X Shirley Liu; David T Scadden Journal: Cell Date: 2013-12-05 Impact factor: 41.582
Authors: Jianfei Qi; Manisha Tripathi; Rajeev Mishra; Natasha Sahgal; Ladan Fazli; Ladan Fazil; Susan Ettinger; William J Placzek; Giuseppina Claps; Leland W K Chung; David Bowtell; Martin Gleave; Neil Bhowmick; Ze'ev A Ronai Journal: Cancer Cell Date: 2013-03-18 Impact factor: 31.743
Authors: Anthony E Rizzardi; Nikolaus K Rosener; Joseph S Koopmeiners; Rachel Isaksson Vogel; Gregory J Metzger; Colleen L Forster; Lauren O Marston; Jessica R Tiffany; James B McCarthy; Eva A Turley; Christopher A Warlick; Jonathan C Henriksen; Stephen C Schmechel Journal: BMC Cancer Date: 2014-04-05 Impact factor: 4.430